Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
DE0005550602
Mon, 15.01.2024
Drägerwerk AG & Co. KGaA
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Preliminary figures 2023: Net sales and earnings significantly above prior year – Dividend increase – Forecast 2024
Lübeck, January 15, 2024 – Dräger's net sales and earnings increased significantly in fiscal year 2023 based on preliminary calculations. This w [ … ]
Wed, 13.12.2023
Drägerwerk AG & Co. KGaA
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Annual forecast raised again
Lübeck, December 13, 2023 – Dräger's net sales and earnings in the current fourth quarter of 2023 have so far exceeded the Company’s expectations. This is due to continued high net sales recognition with high-margin products and ef [ … ]
Wed, 13.12.2023
Drägerwerk AG & Co. KGaA
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Annual forecast raised again
Lübeck, December 13, 2023 – Dräger's net sales and earnings in the current fourth quarter of 2023 have so far exceeded the Company’s expectations. This is due to continued high net sales recognition with high-margin products and ef [ … ]
Mon, 16.10.2023
Drägerwerk AG & Co. KGaA
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Preliminary figures Q3 2023: Significant increase in earnings – full-year forecast raised
Lübeck, October 16, 2023 – Dräger's net sales and earnings increased significantly in the third quarter of 2023 based on preliminary calculations. This was due in particu [ … ]
Fri, 14.07.2023
Drägerwerk AG & Co. KGaA
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Preliminary figures H1 2023: Net sales and earnings significantly above prior year – full-year guidance reaffirmed
Lübeck, July 14, 2023 – Dräger's net sales in the first half of 2023 increased by 19.6 percent (net of currency effects; nominal: 17.7 percent) t [ … ]
Fri, 14.07.2023
Drägerwerk AG & Co. KGaA
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Preliminary figures H1 2023: Net sales and earnings significantly above prior year – full-year guidance reaffirmed
Lübeck, July 14, 2023 – Dräger's net sales in the first half of 2023 increased by 19.6 percent (net of currency effects; nominal: 17.7 percent) t [ … ]
Fri, 05.05.2023
Drägerwerk AG & Co. KGaA
Due to an editorial error, the German version of the ad-hoc notification dated April 17, 2023 on the preliminary financial figures for the first quarter 2023 incorrectly stated the Group order intake for the prior-year quarter in "Mrd." (billion) instead of "Mio." (million): Order intake "3 Monate 2022" (3 months 2022) was erroneously stated as "82 [ … ]
Fri, 05.05.2023
Drägerwerk AG & Co. KGaA
Due to an editorial error, the German version of the ad-hoc notification dated April 17, 2023 on the preliminary financial figures for the first quarter 2023 incorrectly stated the Group order intake for the prior-year quarter in "Mrd." (billion) instead of "Mio." (million): Order intake "3 Monate 2022" (3 months 2022) was erroneously stated as "82 [ … ]
Mon, 17.04.2023
Drägerwerk AG & Co. KGaA
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2023: Strong net sales growth and positive EBIT – forecast for 2023 confirmed
Lübeck, April 17, 2023 – Dräger's net sales in the first quarter of 2023 increased by 18.0 percent (net of currency effects) to around EUR 761 million, thus si [ … ]
Mon, 17.04.2023
Drägerwerk AG & Co. KGaA
Ad-hoc notification in accordance with Sec. 17 of the MAR
Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2023: Strong net sales growth and positive EBIT – forecast for 2023 confirmed
Lübeck, April 17, 2023 – Dräger's net sales in the first quarter of 2023 increased by 18.0 percent (net of currency effects) to around EUR 761 million, thus si [ … ]